Valiant Organics Limited (VALIANTORG) AI Stock Analysis

• Market Cap: ₹8.36B
• Dividend Yield: N/A
• Average Volume (3M): 2.15K
• Price to Earnings (P/E): 161.9
• Beta (1Y): 0.67
• Revenue Growth: 9.59%
• EPS Growth: N/A
• Country: IN
• Employees: 1,073
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): 2.98
• Shares Outstanding: 28,004,610
• 10 Day Avg. Volume: 2,085
• 30 Day Avg. Volume: 2,152
• PEG Ratio: 3.90
• Price to Book (P/B): 1.13
• Price to Sales (P/S): 1.14
• P/FCF Ratio: 31.87
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: ₹292.00 ▼(-4.34% Downside)

Valiant Organics Limited's overall stock score is primarily impacted by its weak financial performance, characterized by declining revenue and profitability, and inconsistent cash flow. Technical analysis indicates a bearish trend with weak momentum. The stock's high P/E ratio suggests overvaluation, further lowering its attractiveness. The absence of earnings call data and corporate events means these factors do not influence the score.

Valiant Organics Limited Business Overview & Revenue Model

Company Description

Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India. Its products include para chlorophenol; ortho chlorophenol; 2,4 di-chlorophenol; 2,4,6 tri- chlorophenol; 2,6 di-chlorophenol; and para nitroaniline. The company's products also comprise ortho chloro para nitro aniline, 6 acetyl OAPSA, OA acetanilide, and PA acetanilide; ortho anisidine, para anisidine, ortho toluidine, para toluidine, IPPCA, FI aniline, and meta chloro aniline; acids; para and ortho amino phenol; and ortho and para nitro anisole. Its products are primarily used as intermediates in agro chemicals, dyes, pigments, pharmaceuticals, cosmetics, specialty chemicals, polymer, and veterinary drugs. The company also exports its products to Europe, Asia, and the United States. Valiant Organics Limited was founded in 1984 and is based in Mumbai, India.

How the Company Makes Money

Valiant Organics generates revenue through several key streams, primarily by manufacturing and selling specialty chemicals and agrochemical products. The company's revenue model is based on direct sales to agricultural businesses, distributors, and other industrial clients. Additionally, Valiant Organiсs capitalizes on partnerships with agricultural firms and research institutions, which help in the development of new products and technologies. The company also leverages its expertise in sustainability to attract clients looking for eco-friendly solutions, thus enhancing its market position and revenue potential. Seasonal demand in the agricultural sector, alongside long-term supply contracts and strategic collaborations, further contribute to its earnings.

Valiant Organics Limited Financial Statement Overview

Summary

Valiant Organics Limited faces challenges with declining revenue and profitability, as well as inconsistent cash flow generation. While the balance sheet reflects a reasonable equity position, the high leverage and declining equity trend are concerning. The company needs to focus on improving profitability and stabilizing cash flows to enhance its financial health.

Income Statement

Valiant Organics Limited has experienced declining revenue over the past few years, with a significant decrease in net income from positive to negative territory. The company shows a negative net profit margin, indicating profitability issues. The gross profit margin has improved recently, but overall profitability remains weak with negative EBIT and EBITDA margins in the latest period.

Balance Sheet

The balance sheet presents a reasonable equity ratio, suggesting a solid asset base relative to liabilities. However, the debt-to-equity ratio indicates significant leverage, which poses potential financial risk. While stockholders' equity exceeds total debt, the declining trend in equity raises concerns about balance sheet robustness.

Cash Flow

The company shows a declining trend in operating cash flow, and free cash flow has been inconsistent, with recent periods showing a decrease. The free cash flow to net income ratio is concerning due to negative net income. Although there is some positive operating cash flow, the overall cash flow position is weak, with potential liquidity challenges.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	7.55B	7.19B	7.23B	10.52B	11.53B	7.55B
Gross Profit	2.74B	2.62B	470.01M	1.81B	2.17B	2.19B
EBITDA	713.53M	615.51M	425.75M	1.77B	2.12B	2.11B
Net Income	50.87M	-37.36M	-83.91M	881.21M	1.13B	1.15B
Balance Sheet
Total Assets	0.00	11.83B	12.48B	12.39B	11.92B	8.76B
Cash, Cash Equivalents and Short-Term Investments	76.45M	131.53M	71.02M	456.71M	499.47M	349.85M
Total Debt	0.00	2.49B	2.57B	2.74B	3.63B	2.09B
Total Liabilities	-7.25B	4.58B	5.19B	4.99B	5.43B	3.68B
Stockholders Equity	7.25B	7.25B	7.29B	6.89B	6.13B	5.02B
Cash Flow
Free Cash Flow	0.00	256.03M	90.70M	862.19M	-1.53B	-562.54M
Operating Cash Flow	0.00	564.32M	840.00M	2.38B	-307.47M	1.15B
Investing Cash Flow	0.00	-209.61M	-649.88M	-1.43B	-1.24B	-1.59B
Financing Cash Flow	0.00	-318.13M	-231.19M	-1.12B	1.67B	486.70M

Valiant Organics Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 305.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Negative. The current price of 305.25 is below the 20-day moving average (MA) of 315.91, below the 50-day MA of 340.94, and below the 200-day MA of 343.44, indicating a bearish trend. The MACD of -13.09 indicates Negative momentum. The RSI at 41.07 is Neutral, neither overbought nor oversold. The STOCH value of 54.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VALIANTORG.

Valiant Organics Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BHARATWIRE	74 Outperform	₹12.08B	16.87	―	―	5.12%	-23.21%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
EVERESTIND	60 Neutral	₹10.45B	104.00	―	0.39%	5.43%	-209.44%
DECCANCE	53 Neutral	₹14.63B	72.93	―	0.06%	-35.17%	-22.63%
HERANBA	48 Neutral	₹12.18B	391.62	―	0.33%	―	―
FAIRCHEMOR	46 Neutral	₹9.89B	106.37	―	0.99%	-19.46%	-80.73%
VALIANTORG	41 Neutral	₹8.36B	161.86	―	―	9.59%	―